Vascular endothelial growth factor variants

   
   

The invention is directed to a method of enhancing the biological activity of vascular endothelial growth factors (VEGF). The invention further concerns certain VEGF variants having enhanced biological activity, methods and means for preparing these variants, and pharmaceutical compositions comprising them. In a further aspect, the invention concerns methods of treatment using, and articles of manufacture containing such VEGF variants.

 
Web www.patentalert.com

< Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells

< Peptides derived from a retrovirus of the HIV group and their use

> Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS

> Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes

~ 00177